Compile Data Set for Download or QSAR
maximum 50k data
Found 8 Enz. Inhib. hit(s) with Target = 'MAP kinase-activated protein kinase 2 [46-400]' and Ligand = 'BDBM605830'
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50:  79.4nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50:  158nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50:  3.16E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50: >1.00E+4nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50: >1.00E+4nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50:  2.51E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50: >3.16E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 2 [46-400](Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605830(US11680056, Example 18A | US11680056, Example 18B ...)
Affinity DataIC50: >3.16E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent